drugset / Trial / NCT07418918

Live Double Combined Lactobacillus Capsule for Vaginal Use(IIb)

NCT07418918 ↗

Phase 2 Completed 66 enrolled Guangdong Longchuangji Pharmaceutical Co., Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a multicenter, randomized, double-blind, placebo-controlled phase IIb clinical study, to evaluate the efficacy and safety of the dual - live Lactobacilli-containing vaginal capsule for the treatment of bacterial vaginosis.

Timeline

Start
2023-01-03
Primary completion
2023-09-01
Completion
2023-11-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Vaginal Lactobacillus Dual Probiotic Capsules Other / unclassified 1e+08 unknown Other

Indications